Target Earnings: Sales Inflection Could Prove Fleeting Amid Mounting Competition

We think investors should await a more attractive risk/reward opportunity before pursuing Target stock.

A row of shopping carts with the Target store logo are shown stacked together.
Securities In This Article
Target Corp
(TGT)

Key Morningstar Metrics for Target

What We Thought of Target’s Earnings

At first blush, Target TGT chalked up decent second-quarter results, as comparable store sales grew 2% and operating margins jumped 160 basis points to 6.4%, resulting in a low-double-digit surge in the stock price. However, upon further review, we’ve taken a tempered stance.

For one, while the turn to positive same-store sales after four quarters of declines is a plus, the firm was lapping a disastrous period last year, during which comparable store sales slumped 5.4% on a 4.8% reduction in transactions following consumer backlash over its Pride month assortment. We recognize that Target has taken strides since then—making necessary investments to enhance its assortment, price points, store experience, and omnichannel supply chain—but we’re skeptical about whether the benefits will hold, given its undifferentiated product assortment and lack of a clear cost advantage relative to other discount retailers.

In this context, the firm’s comp was still a far cry from the 4.2% growth Walmart WMT boasted in its US arm in the most recent period. Beyond the sales line, we also doubt Target is poised to extract much more in the way of margin gains over the next several years, as we believe it will need to continuously reinvest in its supply chain to drive cost efficiencies across procurement and multichannel order fulfillment to deliver competitive prices.

Even as management revised its fiscal 2024 outlook to call for comparable store sales growth in the lower half of its prior aims (flat to up 2%) and EPS of $9.00-$9.70 (from $8.60-$9.60), our preprint marks of 0.5% growth and EPS of $9.13 square with these ranges. As such, we don’t foresee a material change to our fair value estimate of $136 per share. But after the ascent in shares, we now see the stock trading in a range that we’d consider inflated. We think investors should await a more attractive risk/reward opportunity before stocking up.

Target Stock vs. Morningstar Fair Value Estimate

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Erin Lash, CFA

Sector Director
More from Author

Erin Lash, CFA, is a sector director, AM Consumer, for Morningstar*. In addition to leading the sector team, she covers packaged food and household and personal care companies. Beyond managing a team of nine analysts and associates covering an array of consumer firms, Lash also conducts fundamental analysis of 13 multi-billion-dollar market capitalization firms in the packaged food and household and personal care space.

Before joining Morningstar in 2006, Lash spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance. In this capacity, Lash analyzed financial statements, business strategy, and fundamentals of owned companies and potential investments, presenting her recommendations based on this analysis to State Farm portfolio managers for ownership consideration.

Lash holds a bachelor’s degree in finance from Bradley University’s Foster College of Business. She also holds a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. Lash has completed the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

* Morningstar Research Services LLC (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc

Sponsor Center